Product Name
Neuropathy target esterase (Pnpla6), ELISA Kit
Full Product Name
Mouse Neuropathy target esterase ELISA Kit
Product Synonym Names
Neuropathy target esterase; Patatin-like phospholipase domain-containing protein 6; Pnpla6; Nte; 3.1.1.5
Product Gene Name
Pnpla6 elisa kit
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Request for Current Manual Insert
Request Current Manual
3D Structure
ModBase 3D Structure for Q3TRM4
Preparation and Storage
For long term storage, please store the entire kit at -20 degree C.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual.
Other Notes
Small volumes of Pnpla6 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for Pnpla6 purchase
MBS2882759 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the Neuropathy target esterase (Pnpla6) ELISA Kit target analytes in
biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing Pnpla6. The ELISA analytical biochemical technique of the MBS2882759 kit is based on Pnpla6 antibody-Pnpla6 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect Pnpla6 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, Pnpla6. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
NCBI/Uniprot data below describe general gene information for Pnpla6. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001116290.2
[Other Products]
NCBI GenBank Nucleotide #
NM_001122818.2
[Other Products]
UniProt Primary Accession #
Q3TRM4
[Other Products]
UniProt Secondary Accession #
Q7TQD6; Q9R114[Other Products]
UniProt Related Accession #
Q3TRM4[Other Products]
Molecular Weight
129,347 Da
NCBI Official Full Name
neuropathy target esterase isoform 1
NCBI Official Synonym Full Names
patatin-like phospholipase domain containing 6
NCBI Official Symbol
Pnpla6 [Similar Products]
NCBI Official Synonym Symbols
Nte; MSws; AI661849
[Similar Products]
NCBI Protein Information
neuropathy target esterase
UniProt Protein Name
Neuropathy target esterase
UniProt Synonym Protein Names
Patatin-like phospholipase domain-containing protein 6
Protein Family
Neuropathy target esterase
UniProt Gene Name
Pnpla6 [Similar Products]
UniProt Synonym Gene Names
Nte [Similar Products]
UniProt Entry Name
PLPL6_MOUSE
UniProt Comments for Pnpla6
NTE: Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). This deacylation occurs at both sn-2 and sn-1 positions of PtdCho. Its specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy. Defects in PNPLA6 are the cause of spastic paraplegia autosomal recessive type 39 (SPG39); also known as NTE-related motor neuron disorder (NTEMND). Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles. Belongs to the NTE family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: EC 3.1.1.5; Membrane protein, integral; Hydrolase
Cellular Component: endoplasmic reticulum; integral to membrane; membrane
Molecular Function: hydrolase activity; lysophospholipase activity
Biological Process: angiogenesis; lipid catabolic process; lipid metabolic process; metabolic process; organ morphogenesis; phosphatidylcholine metabolic process
Research Articles on Pnpla6
1. the expression of CaMKIIalpha and pCREB exhibits a significant increase in cortex and hippocampus after treatment with PFOS, compared with the control.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.